Our Guiding Principle: Treating Patients Like Family in Action
One of our pharmacists received a call from a patient in distress. The team jumped into action in a way…
DetailsThe Missing Link: Care Management’s Ability to Improve Specialty Pharmacy’s Value Proposition
July 18, 2018 – Marc O’Connor in Specialty Pharmacy Times – Done well, pharmacist-led care management programs attack multiple underlying causes…
DetailsManaged Healthcare Executive: HIV treatment pipeline prospects getting healthier
Curant Health Director of Clinical Services Vickie Andros shares her HIV therapy insights with Managed Healthcare Executive Advancements in…
DetailsTop barriers to patient persistence
Physician time constraints, competing priorities for patients and shortcomings in follow-up initiatives are a few of the top causes of…
DetailsPharma: Meet Your New Neighbors
Executives from patient care, diagnostics, payer and pharma companies converge to share the inside scoop on outcomes-based contracting Curant Health’s…
DetailsRemoving Barriers and Finding Solutions for Non-adherent HIV-Positive Patients: A Care Management Patient Success Story
Curant Health has partnered with Chattanooga Cares to offer a highly coordinated program of clinical services, reporting, and analytics.
DetailsInsights From A Bustling 340B Winter Conference
This year’s 340B Winter Conference was bursting at the seams with attendees. There were over 1,630 registrants for the conference…
DetailsWhat does it take to improve outcomes advocacy? Introducing the PEER Model
Once a prescription is written – just one part of the brand adoption challenge – pharmaceutical manufacturers are limited in…
DetailsFrom Washington, DC to your clinic’s front door: what will we learn together at the 2018 340B Coalition Winter Conference?
Now more than ever, 340B covered entities must ensure they are providing high value, critical care for underserved populations in a way that stands up to scrutiny. What will we learn at 340B Winter 2018?
DetailsRisky business at the 2018 J.P. Morgan Healthcare Conference
What pharma can’t say about outcomes based contracts at JPMorgan 2018. Hint: It’s the “P” word.
Details